HIV In Children
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
REFRACTORY KAWASAKI'S DISEASE
Follow Us : Follow On Facebook Follow On Twitter
RESPONSE OF REFRACTORY KAWASAKI'S DISEASE TO IV METHYL PREDNISOLONE
RCIAPCON 2005

Dr. Ira Shah
Department of Pediatrics,
B.J.Wadia Hospital for Children, Parel Mumbai 400012

Abstract:


Kawasaki's disease is an acute febrile illness seen in young children which may lead to life-threatening vasculitis with predilection for the coronary arteries. Untreated, 25% of cases may develop coronary artery aneurysms. However with conventional treatment of IVIG and high dose aspirin, only 4% are known to develop coronary artery aneurysm. For patients with immunoglobulin resistant Kawasaki's disease, retreatment with IVIG, methyl prednisolone, cyclophosphamide and even Infliximab have been found useful. Most of the refractory Kawasaki's disease respond to 2nd dose of IVIG and rarely require further treatment with intravenous methyl prednisolone. We report 2 cases of Kawasaki's disease who developed coronary aneurysms inspite of 2 courses of IVIG and subsequently responded to intravenous methyl prednisolone.

First case was an eleven months old boy who presented with fever since 15 days, rash and diarrhea since 6 days. On examination, he had pallor, erythematous rash over trunk and back, palmar & plantar edema and erythema, multiple cervical lymphadenopathy, conjunctival congestion and strawberry tongue with dark red lips. Investigations showed anemia, leucocytosis and thrombocytosis. His C-reactive protein (CRP) was positive and ESR was 35 mm at end of 1 hour. Urine routine showed uncountable pus cells with culture growing E.Coli (108/ml). Echocardiography showed mild dilatation of left coronary artery (2.4 mm). He was treated with IV antibiotics and IVIG (2 gm/kg) along with high dose aspirin. After 15 days, a repeat echocardiography revealed mild aneurysm at the ostium of left coronary artery. He was retreated with IVIG. However, his clinical features persisted even after 10 days after retreatment. He was than treated with IV Methyl Prednisolone (30 mg/kg) along with blood transfusion (in view of anemia) following which his clinical symptoms resolved and laboratory parameters also started normalizing.

Second case was a two and a half year old boy with fever and cold since 15 days, bilateral swelling over wrist since 6 days and rash over trunk and face since 2 days. On examination, he had multiple cervical lymphadenopathy, palmar and planter erythema, bilateral wrist swelling with restriction of movement, erythematous rash over trunk and back and right sided pneumonia. Investigation showed thrombocytosis, leucocytosis, anemia, elevated ESR with positive CRP, X-ray chest showed right lower zone consolidation and echocardiography revealed dilated left coronary artery at the ostium (2.8 mm). He was treated with IV Antibiotics, IVIG (2 gm/kg) and high dose Aspirin (100 mg/kg/d). Even after 10 days after IVIG, his clinical symptoms persisted. He was thus given a second course of IVIG (2 gm/kg). After 8 days after 2nd course of IVIG, a repeat echocardiography revealed aneurysm at the ostium of left coronary artery. He was then treated with IV Methyl Prednisolone (30 mg/kg) to which he responded.


Last Updated on 15-06-2006

How to cite this url
RCIAPCON 2005 - Conference Abstracts.Pediatric Oncall [serial online] 2006 [cited 15 June 2006(Supplement 6)];3. Available from:
http://www.pediatriconcall.com/fordoctor/Conference_abstracts/
refractory_kawasaki_methly_prednisolone.asp
 
 
 
Pedi Poll
Today's Poll
For treatment of tuberculosis, should anti TB drugs be given as fixed drug combination {FDC} or singly_?
FDC can be given as it is easy to give just one tablet
Drugs should be used singly to achieve optimum blood levels
Educational Section
 
Health Solutions from our sponsors
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us